Last update:
Oncology news
FDA expands use of kidney cancer drug belzutifan
Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier-stage kidney cancers in ...
2 hours ago
0
0
World's largest genetic study of 'moliness' helps unravel mysteries of melanoma
QIMR Berghofer scientists have uncovered hundreds of genes that play a role in the growth of both moles and melanoma, in a discovery that could lead to new ways of preventing and treating the deadliest form of skin cancer. ...
19 hours ago
0
54
Clinician–scientists identify brain network linked to deadliest childhood brain cancer
A human brain network associated with survival in children with diffuse midline glioma (DMG), the deadliest childhood brain cancer, has been identified by UCL clinician-scientists, raising the possibility of entirely new ...
15 hours ago
0
5
Light switch wakes lung cancer cells up from a protective dormant state
Tumor cells can lapse into a sleep-like state and thereby evade the destructive effect of cancer drugs. In some types of the disease, such as certain forms of lung cancer, this state is triggered by stress hormones in the ...
18 hours ago
0
6
Why some cancers return: Robotic mini tumor tests point to new ways to target persister cells
Cancer drugs can shrink fast-growing tumors. But sometimes a few tumor cells survive. These "persister" cells seed new tumors, forcing cancer patients into arduous cycles of testing and treatment.
22 hours ago
0
6
Why some immunotherapy fails: Tumor-triggered neutrophils can shut down cancer-killing T cells
Certain white blood cells in the immune system, known as neutrophils, can make cancer immunotherapy less effective, according to a new study from Karolinska Institutet published in the journal Immunity. The results show that ...
20 hours ago
0
3
Combo treatment delays multiple myeloma progression and may improve survival, study finds
Patients with multiple myeloma who received a new immunotherapy combination lived significantly longer without their cancer worsening and showed early signs of improved survival in a large international clinical trial.
16 hours ago
0
3
Target with potential to improve CAR T-cell therapy response in patients with blood cancers identified
Researchers at the University of Maryland School of Medicine (UMSOM) have identified a target that may improve the response to CAR T-cell therapy, a treatment for patients with recurrent or difficult-to-treat blood cancers.
17 hours ago
0
1
Silicon-slide imaging could speed cancer diagnosis with 99% agreement, no dyes needed
Scientists at King Abdullah University of Science and Technology (KAUST) have developed a new stain-free imaging platform designed to analyze tissue samples more quickly and consistently, supporting future AI-assisted cancer ...
19 hours ago
0
3
Immune activation may determine success of dual-target CAR T therapy in glioblastoma
Dual-target CAR T-cell therapy for recurrent glioblastoma (GBM), delivered directly into the cerebrospinal fluid (CSF), triggers a broad immune response, with natural killer (NK) cell activation linked to better patient outcomes ...
17 hours ago
0
1
European study shows that prevention in patients with inherited cancer risks produces substantial cost benefits
Screening people with the rare, inherited cancer-causing condition Li-Fraumeni syndrome (LFS) brings both medical and economic benefits to patients and health care systems, according to research to be presented to the annual ...
15 hours ago
0
2
Review on glioma organoid models proposes new classification framework for brain cancer research
Researchers from the Terasaki Institute for Biomedical Innovation, together with key pioneers in glioma biology, neuro-oncology and stem cell biology, have published a comprehensive review in Society for Neuro-Oncology's ...
17 hours ago
0
1
Fixed-duration triplet therapy demonstrates efficacy for patients with relapsed/refractory chronic lymphocytic leukemia
Triplet therapy with pirtobrutinib, venetoclax and rituximab as a two-year fixed-duration therapy improves progression-free survival for patients with relapsed/refractory chronic lymphocytic leukemia (CLL) compared with standard-of-care ...
18 hours ago
0
3
Killing cancer requires immune cells to infiltrate tumors' hostile microenvironment—sugar shields can help them break in
You might think of cancer as a mass of rogue cells that grow uncontrollably. But cancer is more organized and strategic than that. Rather, cancer is a tightly controlled cellular neighborhood that can keep the body's defenses ...
20 hours ago
0
1
New evidence on graft-versus-host disease prevention in stem cell transplants from unrelated donors
Anti-T-lymphocyte globulin (ATLG) for the prevention of graft-versus-host disease (GvHD) reduces complications and infection-related mortality compared with post-transplant cyclophosphamide (PTCy) in allogeneic hematopoietic ...
17 hours ago
0
1
Experimental treatment directly kills prostate tumor cells while reawakening antitumor immunity
Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing antitumor immunity, according to a preclinical study led by investigators at Weill Cornell ...
Jun 15, 2026
0
6
Review focuses on sustaining smoking cessation support in lung cancer screening programs
Researchers from Flinders University say that building lung cancer screening programs that include strong, consistent and long-term quit-smoking support could play a crucial role in preventing smoking-related deaths. The ...
Jun 15, 2026
0
2
How H. pylori uses extracellular vesicles to drive stomach cancer
Scientists at the Hudson Institute of Medical Research have discovered how Helicobacter pylori, the bacterium responsible for most stomach cancers and peptic ulcers, delivers a key disease-causing protein into human cells. ...
Jun 15, 2026
0
2
FDA approves combination therapy for higher-risk clear cell kidney cancer after surgery
The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component ...
Jun 15, 2026
0
3
Well-timed nudges help care providers to honor the wishes of patients with cancer according to study
New research in the June 2026 issue of Journal of the National Comprehensive Cancer Network finds that small, targeted prompts delivered to both patients and providers at the right moment can significantly increase the number ...
Jun 15, 2026
0
1
Why glioblastoma keeps beating treatment: Hidden signaling axis could open new drug path
An international study led by a scientist at the University of Ottawa Faculty of Medicine is opening new frontiers in the fight against glioblastoma (GB), a devastating cancer behind the most malignant and treatment-resistant ...
Jun 14, 2026
0
9
Integrating genetic origin data with tumor analyses enables better prediction of survival
New research to be presented today at the annual conference of the European Society of Human Genetics shows that a cancer patient's genetic ancestry can have a significant effect both on how their disease progresses and their ...
Jun 14, 2026
0
25
Sugar-coated CAR-T cells survive longer and shrink lymphoma tumors in mice
Scientists at Florida International University may have found a way to make a powerful cancer treatment work even better. The treatment, called CAR-T therapy, uses a patient's own immune cells to fight cancer. Doctors remove ...
Jun 13, 2026
0
8
How a simple blood test could help detect heart damage during breast cancer treatment
Modern breast cancer screening and treatment have transformed survival. Many women now live long and healthy lives after diagnosis, thanks to increasingly effective chemotherapy and targeted therapies: medicines designed ...
Jun 13, 2026
0
19
Women's thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
Longer lifetime exposure to female hormones may increase the risk of thyroid cancer in women, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago. The research suggests reproductive ...
Jun 13, 2026
0
3
